In 2014, International Community Foundation (ICF), Scripps Health, and Prosalud piloted a cervical cancer screening program across Mexico to validate new technologies in an effort to help ensure all 48.4 million women at risk for developing cervical cancer - the most common cancer in women aged 15-49 years old - get the preventative care they deserve. While current prevention efforts are far reaching, screening rural and indigenous women continues to be a challenge as a result of the distance to health care centers, awareness, and cultural norms.
Made possible by a grant from the Vodafone Americas Foundation Wireless Innovation Project, the group of diverse partners worked to:
Over the course of the partnership, 785 women were screened for cervical cancer with the EVA System, an FDA cleared and CE certified mobile colposcope, to reach vulnerable, high-risk women in underserved communities. Partner staff shared, “For the Community, this was a strong and rewarding program, given the outreach focus. Patients were able to start and conclude successful treatment, after referral to Pro Health Medical Center. Providers who were trained included both medical and social service interns, who were motivated to use to the [EVA System colposcope] because of the training aspect, and engagement of the software in the device.”
A ProSalud community outreach effort, with cervical cancer prevention as part of a broader reproductive health curriculum.
The images collected with the EVA System laid the groundwork for MobileODT’s machine learning and artificial intelligence program that will use algorithms that help identify high-risk patients and provide decision support for any next steps or treatment in the future.
While we still have much work to do drastically reduce the 5,000 deaths annually from the disease in Mexico, we know that new approaches to ensure no woman is left behind, has the power to help end deaths from cervical cancer in a generation.
Vizient, Inc. announced MobileODT as the winner of its 2017 Innovation Challenge, an interactive competition between four early-stage growth health care companies. The competition was held on Wednesday, September 13, during the opening session of the Vizient Clinical Connections Summit at the Colorado Convention Center in Denver.
The Vizient Innovation Challenge gave Vizient members a firsthand look at four new and compelling products designed to help improve the quality and delivery of health care. The competing companies were chosen from a pool of 40 submissions that were sourced from an outreach that spanned 328 companies in 29 states, Washington D.C. and 10 countries.
Each finalist gave an eight-minute pitch presentation then answered questions from an expert panel that included the chief executive officers from two Vizient member hospitals. At the conclusion of the presentations, the audience of roughly 2,000 health care professionals attending the 2017 Vizient Clinical Connections Summit voted and selected MobileODT as the winner of the 2017 Innovation Challenge.
Designed to combat the barriers between people all over the world and quality health care access, MobileODT turns mobile technologies into intelligent visual diagnostic tools that allows any health provider anywhere on the globe to conduct visual inspections at the level of an expert practitioner.
“It is exciting to meet these innovators and see products that have the potential to improve the quality of care and the health care experience for patients,” said Byron Jobe, president, chief administrative and financial officer for Vizient. “We thank each of this year’s contestants for sharing their innovations with our members and congratulate MobileODT on winning this year’s Innovation Challenge.”
About Vizient, Inc.
Vizient, Inc., the largest member-driven health care performance improvement company in the country, provides innovative data-driven solutions, expertise and collaborative opportunities that lead to improved patient outcomes and lower costs. Vizient’s diverse membership base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents more than $100 billion in annual purchasing volume.